Dermatology
News
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasis
Survival rates were highest for rituximab in rheumatoid arthritis and golimumab in axial spondyloarthritis in a study of two Danish registries.
News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
News
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis finds
The results highlight the need for proper assessment of body weight and cardiovascular risk factors in patients with PsA at the onset of disease...
News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
News
Why dermatologists should support artificial intelligence efforts
“I really do believe this is going to be the future,” Dr. Vishal A. Patel said.
News
Pioneering test predicts return of malignant melanoma
The test will aid clinicians to identify genuinely low-risk patients diagnosed with an early-stage melanoma, the study’s senior author said.
News
Antibiotic choices for inpatients with SSTIs vary by race
Clindamycin was more often prescribed for Black patients than White patients.
Conference Coverage
Key questions to ask atopic dermatitis patients with sleep complaints
Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.
News
Soon-to-be medical student awarded $10K after spotting melanoma
“The mole on the back of your neck is possibly cancerous. Please go see a doctor!”
Conference Coverage
Atopic dermatitis can be especially burdensome in the elderly
There is good data on higher relative risk of osteoporosis/fractures and dementia specifically among older adults with AD.